Announced Sat, 27 Jun · 11:23 IST

Open Offer by Dugar Family to Acquire 26% Stake in Colinz Laboratories at Rs 54/share

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+10.2%1-day move

₹75.55

prior close

₹79.32

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+10.2+15.1+8.0+2.6-2.5-12.0+5.8———

Up moveDown movePending

AI summary

Detailed Public Statement issued for Open Offer by Annjana, Likhitta, and Antariksh Dugar along with PAC Padam Dugar to acquire up to 6,54,966 shares (26%) of Colinz Laboratories from public shareholders at Rs 54 per share, totaling about Rs 3.54 crore. Triggered by SPA signed June 18, 2026 with promoter Vijaya Mani for 8,70,500 shares at Rs 50 per share. Post-offer acquirer holding may reach 75.56%. Colinz is a Mumbai-based pharma formulations maker.

Likely market impact

Public shareholders can tender shares at Rs 54 per share in cash. Offer is mandatory under SEBI takeover rules following change of control from Vijaya Mani to Dugar family.